The Patent Finder

Aadigen, LLC

10 patents currently held · Updated Nov 20, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 1, 2027
    The maintenance fee for Peptides and nanoparticles for intracellular delivery of molecules (US 11,713,336) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Cell penetrating peptides for intracellular delivery of molecules (US 10,421,784) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,376,468Cell Penetrating Peptides for Intracellular Delivery of Molecules
In force
 · High confidence
In forceHigh confidence
US 10,287,581Cell penetrating peptides for intracellular delivery of molecules
In force
 · USPTO record
In forceUSPTO record
US 9,579,395Cell penetrating peptides for intracellular delivery of molecules
In force
 · USPTO record
In forceUSPTO record
US 9,598,465Cell penetrating peptides for intracellular delivery of molecules
In force
 · USPTO record
In forceUSPTO record
US 10,111,965Cell Penetrating Peptides for Intracellular Delivery of Molecules
In force
 · Low confidence
In forceLow confidence
US 10,421,784Cell penetrating peptides for intracellular delivery of molecules
In force
 · USPTO record
In forceUSPTO record
US 10,745,440Peptides and nanoparticles for intracellular delivery of molecules
In force
 · USPTO record
In forceUSPTO record
US 11,713,336Peptides and nanoparticles for intracellular delivery of molecules
In force
 · USPTO record
In forceUSPTO record
US 12,357,695Peptides and Nanoparticles for Intracellular Delivery of Molecules
In force
 · High confidence
In forceHigh confidence
US 12,774,463Compositions for Treating Cancer with Kras Mutations and Uses Thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 1 patent in force now held by others · 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned · 5 no status recorded

Showing 1 to 9 of 9, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/235,292Peptides and Nanoparticles for Intracellular Delivery of MoleculesJun 11, 2025Pending
18/984,678Peptides and Nanoparticles for Intracellular Delivery of Genome-Editing MoleculesDec 17, 2024Pending
18/017,644Compositions and Methods for Treating Viral InfectionsJul 23, 2021Pending
16/777,742Jan 30, 2020No status recorded
16/756,442Oct 15, 2018No status recorded
16/637,723Aug 9, 2018No status recorded
15/701,298Sep 11, 2017No status recorded
16/305,003Peptides and Nanoparticles for Intracellular Delivery of Genome-Editing MoleculesMay 26, 2017Abandoned
14/399,909May 14, 2013No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited